Arnold Mixon

PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors

Alena Gros, Paul F. Robbins, Xin Yao et al. · Journal of Clinical Investigation · 2014 · 1.1K citations · Full text

Life Sciences, Immunology, Oncology +17

Phase I trial of subcutaneous interleukin-6 in patients with advanced malignancies.

Jeffrey S. Weber, James Chih‐Hsin Yang, S L Topalian et al. · Journal of Clinical Oncology · 1993 · 218 citations

Pharmacy, Oncology, Pharmacology +15

Phase 1 Study in Patients With Metastatic Melanoma of Immunization With Dendritic Cells Presenting Epitopes Derived From the Melanoma-Associated Antigens MART-1 and gp100

Monica C. Panelli, John R. Wunderlich, Justin Jeffries et al. · Journal of Immunotherapy · 2000 · 178 citations

Life Sciences, Immunology, Oncology +13

Loss of HLA haplotype and B locus down-regulation in melanoma cell lines.

Franco Marincola, Peter Shamamian, Richard B. Alexander et al. · The Journal of Immunology · 1994 · 168 citations

Life Sciences, Immunology, Oncology +15

Quantitative correlation between HLA class I allele expression and recognition of melanoma cells by antigen-specific cytotoxic T lymphocytes.

Licia Rivoltini, Kathleen C. Barracchini, Vincenzo Viggiano et al. · PubMed · 1995 · 164 citations

Life Sciences, Immunology, Oncology +17